Navigation Links
Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
Date:11/18/2009

Cancer Treatment Centers of America will be First in Country to Offer New Technology from Italy

PHILADELPHIA, Nov. 18 /PRNewswire/ -- A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America(R) (CTCA) in Philadelphia. CTCA will become the first in the country to offer this treatment option using the Novac7 technology from Rome, Italy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091118/DC13290 )

Intraoperative Radiation Therapy (IORT) technology allows patients to receive radiation treatment, delivered with the same power and precision as other advanced radiation techniques, while still in the operating room undergoing surgery, often without any additional outpatient radiation treatment visits, and with fewer side effects. IORT also offers patients better cosmetic results and improved quality of life as the need for additional radiation treatment is minimized or eliminated altogether.

"Women in Italy have had access to the therapeutic and quality of life benefits of IORT for years, but until this point, traditional breast cancer treatments in the United States involved surgery followed by 5-6 weeks of radiation or chemotherapy," said Director of Radiation Oncology Pablo Lavagnini, MD. "Sadly many women don't have access to radiation treatments and those who do are left struggling to juggle a demanding treatment regimen with work and family obligations at home. IORT offers a possible solution."

So how does it work? IORT requires a team approach. While most women with early stage breast cancer are eligible for this procedure, the first step is determining that the patient is a candidate for surgery and IORT. After the surgeon has removed the tumor with a partial mastectomy or lumpectomy, the radiation team will enter the operating room and deliver a single dose of radiation using a mobile linear accelerator. In two to three minutes, the radiation is precisely delivered to the area where the tumor was removed, shielding or protecting normal tissues from potential radiation damage, allowing a full dose of radiation to be delivered where needed and sparing the surrounding structures.

While IORT will offer significant medical and quality of life benefits for breast cancer patients, it will also be a valuable tool for many patients battling other cancer types including: head and neck, stomach, pancreas, rectum, gynecological, prostate and soft tissue sarcomas (especially retroperitoneal). For patients who must receive additional radiation therapy following surgery, they can receive a "boost" of radiation during IORT, shielding the surrounding tissues from radiation damage while allowing a higher dose to the area requiring treatment.

Cancer Treatment Centers of America in Philadelphia expects to begin treating breast cancer patients with IORT by the end of January 2010, as the latest addition to the hospital's fully integrative model of care. For more information, visit cancercenter.com.

About Cancer Treatment Centers of America:

Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. For more information about Cancer Treatment Centers of America, go to cancercenter.com.

SOURCE Cancer Treatment Centers of America


'/>"/>
SOURCE Cancer Treatment Centers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medical Tests Hit Heart Patients With High Doses of Radiation
2. Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
3. Radiation Therapy Options for Mesothelioma Patients Sponsored by MesoCare.org
4. PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
5. Radiation Therapy Options in Mesothelioma by Veronica Garza of MD Anderson Sponsored by MesoCare.org
6. PSA Reading Could Predict Post-Radiation Survival
7. Shorter, More Intense Radiation OK for Some Breast Cancers
8. Chemo-radiation before prostate removal may prevent cancer recurrence
9. Focused Radiation May Help Some With Lung Cancer
10. CMS Limits Proposed Medicare Cuts To Radiation Oncology
11. Short-Term Hormone Therapy Added to Radiation Increases Survival for Medium-Risk, But Not Low-Risk, Prostate Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... FRANCE (PRWEB) , ... January 21, 2017 , ... ... the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. ... Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create ...
(Date:1/21/2017)... ... January 21, 2017 , ... In the United States, 20 million women ... of recovery, they often feel shame for having struggled with an eating disorder as ... the workshop, “Rising Strong in Life After an Eating Disorder” -- to be featured ...
(Date:1/20/2017)... Texas (PRWEB) , ... January 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... the bible in homes across the world. Yisrayl says this generation is a time like ... is to turn to the Bible. , Yisrayl says he does not want to sound ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Lice Troopers, the ... cases in families with school-aged children since the holiday season. , “It happens ... with their families, sharing hugs and taking photos, which is the head-to-head gateway that ...
(Date:1/20/2017)... ... 20, 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions ... said Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique ... Mystique lens flare and light leak transitions have a very high-dynamic range for super ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Stealth BioTherapeutics Inc. ( ... treat mitochondrial dysfunction, today announced new additions to its ... as Chief Medical Officer, and Daniel Geffken ... that Jim Carr , Pharm.D. has been promoted ... are pleased to welcome Doug and Daniel to our ...
(Date:1/19/2017)... 19, 2017 James ... & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European ... touchONCOLOGY, an article by James Gilbart ...
(Date:1/19/2017)... , January 19, 2017 ... Otsuka in the Milner Therapeutics Consortium   ... in Cambridge   ... PFE ) as a partner to the ... Consortium, which enables the efficient transfer of materials between ...
Breaking Medicine Technology: